2023. Individuals interested in joining the AACR and sponsoring a clinical trial or late-breaking abstract must submit an application for membership no later than January 3, 2024. Membership questions may be directed
2023. Individuals interested in joining the AACR and sponsoring a clinical trial or late-breaking abstract must submit an application for membership no later than January 3, 2024. Membership questions may be directed
Frequency: Annual Country of Study: Any country Application Procedure: To be considered, please submit an electronic version of a dissertation abstract that is no longer than 15 double-spaced pages (including appendices, tables, figures, and references). Closing Date: 1 January Additional Information...
[11]Trastuzumab deruxtecan (T-DXd) in Chinese patients (pts) with previously treated HER2 mutant non-small cell lung cancer (NSCLC): primary analysis from the Phase 2 DESTINY-Lung05 (DL-05) trial. Abstract CT248...
IO Biotech (Nasdaq: IOBT) today announced that an abstract has been accepted for presentation at the American Association for Cancer Research Annual Meeting 2024 (AACR 2024), taking place April 5-10, 2024 in San Diego, CA.
2024 AACR 美国癌症研究协会(AACR)年会是世界上规模最大的癌症研究会议之一,会议关注肿瘤早期研究和创新进展,汇集肿瘤领域的前沿的研究成果。2024年AACR年会于4月5日-4月10日在美国圣地亚哥盛大召开。 本次大会上,AACR官网已公布部分摘要,包括REGULAR ABSTRACT SESSIONS(定期摘要会议)中Minisymposia和Poster Sessions部分。
链接:https://aacrjournals.org/cancerres/article/84/6_Supplement/1773/735532/Abstract-1773-Deciphering-the-roles-of-germline?searchresult=1 6.题目:Spatial-resolved single-cell analysis of the tumor microenvironment in Alaska Native colorectal cancer patients ...
链接:https://aacrjournals.org/cancerres/article/84/6_Supplement/1773/735532/Abstract-1773-Deciphering-the-roles-of-germline?searchresult=1 6.题目:Spatial-resolved single-cell analysis of the tumor microenvironment in Alaska Native colorectal cancer patients ...
Date: Monday, April 8, 2024 Candidate: BNT324/DB-1311 Session Title:Phase I Clinical Trials in Progress 2 Abstract Title: “A phase 1/2a, multicenter, open-label, first-in-human study to assess the safety, tolerability, pharmacokinetics, and prelimi...
prostate cancer (Neo-Red-P) [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 2 (Late-Breaking, Clinical Trial, and Invited Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(7_Suppl):Abstract nr ...